BioPorto A/S (THOXF)
USD 0.29
(0.0%)
USD 0.29
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7.25 Million DKK | -31.89% |
| 2022 | 10.64 Million DKK | -18.33% |
| 2021 | 13.03 Million DKK | 22.05% |
| 2020 | 10.67 Million DKK | 187.84% |
| 2019 | 3.71 Million DKK | 2531.21% |
| 2018 | 141 Thousand DKK | -22.53% |
| 2017 | 182 Thousand DKK | 184.38% |
| 2016 | 64 Thousand DKK | -25.58% |
| 2015 | 86 Thousand DKK | -18.1% |
| 2014 | 105 Thousand DKK | -14.63% |
| 2013 | 123 Thousand DKK | -99.07% |
| 2012 | 13.22 Million DKK | -14.97% |
| 2011 | 15.55 Million DKK | -3.11% |
| 2010 | 16.05 Million DKK | 387.82% |
| 2009 | 3.29 Million DKK | 0.0% |
| 2008 | - DKK | 0.0% |
| 2007 | - DKK | -100.0% |
| 2006 | 4.02 Million DKK | 0.0% |
| 2005 | - DKK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 6.53 Million DKK | -9.93% |
| 2024 Q2 | 5.71 Million DKK | -12.42% |
| 2023 Q1 | 6.56 Million DKK | -38.32% |
| 2023 Q2 | 5.63 Million DKK | -14.18% |
| 2023 Q4 | 7.25 Million DKK | 48.29% |
| 2023 Q3 | 4.88 Million DKK | -13.24% |
| 2023 FY | 7.25 Million DKK | -31.89% |
| 2022 Q3 | 12.13 Million DKK | -1.73% |
| 2022 Q4 | 10.64 Million DKK | -12.27% |
| 2022 Q1 | 9.58 Million DKK | -26.48% |
| 2022 Q2 | 12.34 Million DKK | 28.85% |
| 2022 FY | 10.64 Million DKK | -18.33% |
| 2021 FY | 13.03 Million DKK | 22.05% |
| 2021 Q1 | 7.99 Million DKK | -25.12% |
| 2021 Q3 | 10.9 Million DKK | 40.82% |
| 2021 Q4 | 13.03 Million DKK | 19.53% |
| 2021 Q2 | 7.74 Million DKK | -3.16% |
| 2020 Q3 | 8.72 Million DKK | -8.95% |
| 2020 Q1 | 996 Thousand DKK | -73.15% |
| 2020 FY | 10.67 Million DKK | 187.84% |
| 2020 Q4 | 10.67 Million DKK | 22.44% |
| 2020 Q2 | 9.57 Million DKK | 861.75% |
| 2019 Q1 | 1.98 Million DKK | 1307.8% |
| 2019 FY | 3.71 Million DKK | 2531.21% |
| 2019 Q2 | 1.19 Million DKK | -39.9% |
| 2019 Q4 | 3.71 Million DKK | 520.4% |
| 2019 Q3 | 598 Thousand DKK | -49.87% |
| 2018 Q3 | 139 Thousand DKK | 0.0% |
| 2018 Q2 | - DKK | 0.0% |
| 2018 Q1 | - DKK | -100.0% |
| 2018 FY | 141 Thousand DKK | -22.53% |
| 2018 Q4 | 141 Thousand DKK | 1.44% |
| 2017 Q3 | - DKK | -100.0% |
| 2017 FY | 182 Thousand DKK | 184.38% |
| 2017 Q2 | 27 Thousand DKK | -20.59% |
| 2017 Q1 | 34 Thousand DKK | -46.88% |
| 2017 Q4 | 40 Thousand DKK | 0.0% |
| 2016 Q1 | 58 Thousand DKK | -32.56% |
| 2016 Q4 | 64 Thousand DKK | 39.13% |
| 2016 FY | 64 Thousand DKK | -25.58% |
| 2016 Q3 | 46 Thousand DKK | -11.54% |
| 2016 Q2 | 52 Thousand DKK | -10.34% |
| 2015 Q1 | 80 Thousand DKK | -23.81% |
| 2015 FY | 86 Thousand DKK | -18.1% |
| 2015 Q4 | 86 Thousand DKK | 22.86% |
| 2015 Q3 | 70 Thousand DKK | -6.67% |
| 2015 Q2 | 75 Thousand DKK | -6.25% |
| 2014 Q2 | 96 Thousand DKK | -4.95% |
| 2014 Q1 | 101 Thousand DKK | -17.89% |
| 2014 FY | 105 Thousand DKK | -14.63% |
| 2014 Q3 | 92 Thousand DKK | -4.17% |
| 2014 Q4 | 105 Thousand DKK | 14.13% |
| 2013 Q1 | 13.69 Million DKK | 3.57% |
| 2013 Q4 | 123 Thousand DKK | 0.0% |
| 2013 FY | 123 Thousand DKK | -99.07% |
| 2013 Q2 | 8 Million DKK | -41.6% |
| 2013 Q3 | - DKK | -100.0% |
| 2012 FY | 13.22 Million DKK | -14.97% |
| 2012 Q2 | 16.57 Million DKK | 6.61% |
| 2012 Q4 | 13.22 Million DKK | -15.63% |
| 2012 Q1 | 15.54 Million DKK | -0.05% |
| 2012 Q3 | 15.67 Million DKK | -5.42% |
| 2011 Q2 | 15.99 Million DKK | -5.1% |
| 2011 Q4 | 15.55 Million DKK | -0.58% |
| 2011 Q3 | 15.64 Million DKK | -2.2% |
| 2011 Q1 | 16.85 Million DKK | 5.01% |
| 2011 FY | 15.55 Million DKK | -3.11% |
| 2010 Q4 | 16.05 Million DKK | 0.12% |
| 2010 Q1 | 3.6 Million DKK | 9.57% |
| 2010 FY | 16.05 Million DKK | 387.82% |
| 2010 Q3 | 16.03 Million DKK | 306.98% |
| 2010 Q2 | 3.94 Million DKK | 9.26% |
| 2009 Q4 | 3.29 Million DKK | 0.0% |
| 2009 FY | 3.29 Million DKK | 0.0% |
| 2008 FY | - DKK | 0.0% |
| 2007 FY | - DKK | -100.0% |
| 2006 FY | 4.02 Million DKK | 0.0% |
| 2005 FY | - DKK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -223.661% |
| Arrayit Corporation | 1.07 Million USD | -572.438% |
| Atlantic International Corp. | 2.93 Million USD | -147.399% |
| Biocept, Inc. | 12.1 Million USD | 40.127% |
| Bioqual, Inc. | 3.58 Million USD | -102.12% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -9884.301% |
| DermTech, Inc. | 54.39 Million USD | 86.671% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 98.464% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -49.981% |
| iMD Companies, Inc. | 1.12 Million USD | -547.235% |
| IDenta Corp. | 789.14 Thousand USD | -818.715% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 35.222% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -16435.523% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 9.881% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -89.498% |
| NovelStem International Corp. | 3.57 Million USD | -102.82% |
| Optigenex Inc. | 8.94 Million USD | 18.91% |
| PharmChem, Inc. | 77.35 Thousand USD | -9272.616% |
| Proteome Sciences plc | 17.15 Million USD | 57.735% |
| Response Genetics, Inc | 6.37 Million USD | -13.761% |
| Rennova Health, Inc. | 15.32 Million USD | 52.705% |
| RushNet, Inc. | 4.82 Million USD | -50.318% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -3401.84% |
| Stella Diagnostics Inc. | 6.2 Million USD | -16.923% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -302.759% |
| Todos Medical Ltd. | 38.34 Million USD | 81.094% |